Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL255968 | 0.69 | GPR3 (0.46) | GPR3PLCG1 | |
| SCHEMBL3536271 | 0.68 | GPR3 (0.33) | GPR3PLCG1 | |
| SCHEMBL3966527 | 0.68 | GPR3 (0.33) | GPR3PLCG1 | |
| SCHEMBL10517257 | 0.67 | GPR3 (0.32) | GPR3PLCG1 | |
| SCHEMBL1196801 | 0.66 | GPR3 (0.39) | GPR3 | |
| SCHEMBL30365485 | 0.65 | MEN1 (0.32) | GPR3PLCG1 | |
| SCHEMBL30708217 | 0.61 | CXCR2 (0.35) | GPR3PLCG1 | |
| SCHEMBL19194985 | 0.61 | CXCR2 (0.35) | GPR3PLCG1 | |
| SCHEMBL6756663 | 0.61 | MAPK1 (0.35) | — | |
| SCHEMBL3714644 | 0.60 | CA12 (0.35) | GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4997836-A | Inhibitor of platelet activating factor | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-03-05 | — | — | US | disclosed |
| US-4937246-A | ABSORBED EASILY FROM INTESTINES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-06-26 | — | — | US | disclosed |
| EP-0369810-A2 | PAF antagonists as anti-hyperendothelinemia agents | Takeda Chemical Industries, Ltd. (JP) | 1990-05-23 | — | — | EP | disclosed |
| EP-0368670-A1 | Trisubstituted piperazine compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1990-05-16 | — | — | EP | disclosed |